文献速递细菌感染、耐药与抗菌药物

免疫优势表位特异性单克隆抗体混合物改善金黄色葡萄球菌菌血症小鼠生存

An Immunodominant Epitope-Specific Monoclonal Antibody Cocktail Improves Survival in a Mouse Model of Staphylococcus aureus Bacteremia.
PubMed 文献 · J Infect Dis · 2021-01-01

其中4株强效抗体组成混合物,可有效对抗耐甲氧西林金黄色葡萄球菌252株感染,保护效果与细菌负荷降低和感染病理减轻相关。

要点

  • 鉴定出7个B细胞免疫优势表位,含5个新表位。
  • 4株强效单抗组成混合物对MRSA 252株感染有保护效果。
  • 保护效力与细菌负荷降低及感染病理减轻相关。

核心结论

  • 该单克隆抗体混合物是颇具前景的金黄色葡萄球菌疫苗候选物。

研究设计与样本

  • 利用重叠肽和rFSAV免疫志愿者抗血清鉴定B细胞免疫优势表位,并制备单克隆抗体。

主要发现

  • 在rFSAV的4个抗原上鉴定出7个B细胞免疫优势表位,包括5个新表位:Hla48-65、IsdB402-419、IsdB432-449、SEB78-95和MntC7-24。
  • 4株强效单抗组成的混合物能有效对抗金黄色葡萄球菌感染,保护效力与细菌负荷降低和感染病理减轻相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To date, no vaccine or monoclonal antibody (mAb) against Staphylococcus aureus has been approved for use in humans. Our laboratory has developed a 5-antigen S. aureus vaccine (rFSAV), which is now under efficacy evaluation in a phase 2 clinical trial. In the current study, using overlapping peptides and antiserum from rFSAV-immunized volunteers, we identified 7 B-cell immunodominant epitopes on 4 antigens in rFSAV, including 5 novel epitopes (Hla48-65, IsdB402-419, IsdB432-449, SEB78-95, and MntC7-24). Ten immunodominant epitope mAbs were generated against these epitopes, and all of them exhibited partial protection in a mouse sepsis model. Four robust mAbs were used together as an mAb cocktail to prevent methicillin-resistant S. aureus strain 252 infection. The results showed that the mAb cocktail was efficient in combating S. aureus infection and that its protective efficacy correlated with a reduced bacterial burden and decreased infection pathology, which demonstrates that the mAb cocktail is a promising S. aureus vaccine candidate.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zeng H, Zhang J, Song X, et al. An Immunodominant Epitope-Specific Monoclonal Antibody Cocktail Improves Survival in a Mouse Model of Staphylococcus aureus Bacteremia. J Infect Dis. 2021. PMID: 32959055. doi:10.1093/infdis/jiaa602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。